VA-ECMO联合IABP在急性心肌梗死PCI术后并发难治性心源性休克中的应用

廖付军; 鲍海龙; 韦波; 谢登海; 李洁琪; 李伟

doi:10.13201/j.issn.1001-1439.2021.11.005

VA-ECMO联合IABP在急性心肌梗死PCI术后并发难治性心源性休克中的应用

- 1. 贵州医科大学附属医院心血管内科(贵阳, 550001);
- 2. 贵州医科大学
基金项目:
国家自然科学基金项目(No:81960047)

贵州省科技计划项目(No:黔科合支撑[2021]一般063)

详细信息

通讯作者: 李伟,E-mail:liwei249188@sina.com

中图分类号: R542.2

收稿日期: 2021-05-26

Application of VA-ECMO combined with IABP in refractory cardiogenic shock after PCI in acute myocardial infarction

- 1. Department of Cardiology, the Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, China;
- 2. Guizhou Medical University

More Information

Corresponding author: LI Wei, E-mail: liwei249188@sina.com

Received Date: 26 May 2021

摘要

摘要: 目的:观察动-静脉体外膜肺氧合(VA-ECMO)联合主动脉内球囊反搏(IABP)对急性心肌梗死PCI术后合并难治性心源性休克患者的临床疗效及转归。方法:回顾性分析2019年12月—2021年4月我院心内科收治的急性心肌梗死PCI术后合并难治性心源性休克同时接受VA-ECMO及IABP治疗的11例患者,收集并观察临床基线资料、冠状动脉(冠脉)病变特点及介入治疗情况、辅助治疗前后血流动力学变化、血管活性药物使用情况、血气分析指标变化情况、ECMO生存评分(SAVE评分)、术后并发症及临床结局等。结果:11例患者当中,VA-ECMO及IABP治疗前后心脏指数(CI)、平均动脉压(MAP)、心率(HR)、心脏射血分数(EF)、血管活性药物使用剂量、乳酸(Lac)、混合静脉氧饱和度(SvO₂)指标差异有统计学意义(P<0.05)。其中院内死亡3例,存活8例,存活率72.7%,发生消化道大出血2例(18.2%),急性肾衰竭2例(18.2%),重度感染1例(9.1%),脑出血1例(9.1%)。结论:VA-ECMO联合IABP可为急性心肌梗死并难治性心源性休克患者提供有效循环支持,在改善重要脏器功能及纠正心源性休克、代谢性酸中毒中起重要作用,同时准确把握VA-ECMO及IABP的使用时机及预防并发症出现可有效提高治疗成功率。
- 难治性心源性休克 /
- 主动脉球囊反搏 /
- 体外膜肺氧合 /
- 急性心肌梗死
Abstract: Objective: To observe the clinical efficacy and outcome analysis of venoarterial extracorporeal membrane oxygenation(VA-ECMO) combined with intra-aortic balloon counterpulsation(IABP) in patients with acute myocardial infarction combined with refractory cardiogenic shock after PCI.Methods: A retrospective analysis of 11 patients were analyzed in acute myocardial infarction combined with refractory cardiogenic shock treated with VA-ECMO and IABP after PCI in the Department of Cardiology of our hospital from December 2019 to April 2021. Clinical baseline data were collected and observed, such as coronary artery disease characteristics and interventional treatment, hemodynamic changes before and after adjuvant treatment, vasoactive drug use, changes in blood gas analysis indicators, ECMO survival score(SAVE score), postoperative complications and clinical outcomes.Results: In 11 patients, the differences were statistically significant in degree(SvO₂) index, cardiac index(CI), mean arterial pressure(MAP), heart rate(HR), cardiac ejection fraction(EF), vasoactive drug dosage, lactic acid(Lac), mixed venous oxygen saturation before and after VA-ECMO and IABP treatment(P<0.05). Among them, 3 cases died in the hospital, 8 cases survived with survival rate(72.7%). The 2 cases were gastrointestinal hemorrhage(18.2%), 2 cases were acute renal failure(18.2%), 1 case was severe infection(9.1%), and 1 case was cerebral hemorrhage(9.1%).Conclusion: VA-ECMO combined with IABP can provide effective circulatory support for acute myocardial infarction and refractory cardiogenic shock, and play an important role in improving the function of important organs and correcting cardiogenic shock and metabolic acidosis.
- refractory cardiogenic shock /
- intra-aortic balloon pump /
- extracorporeal membrane oxygenation /
- acute myocardial infarction

HTML全文

参考文献(21)

[1]	霍勇.中国胸痛中心建设理论与医学模式[J].中国介入心脏病学杂志,2021,29(1):1-3.
[2]	李思艺,丁寻实,叶滔,等.胸痛中心模式下急性冠脉综合征救治和预后的年龄差异性分析——一项多中心回顾性研究[J].中华危重病急救医学,2021,33(3):318-323.[J].
[3]	Reyentovich A,Barghash MH,Hochman JS.Management of refractory cardiogenic shock[J].Nat Rev Cardiol,2016,13(8):481-492.
[4]	Taleb I,Koliopoulou AG,Tandar A,et al.Shock team approach in refractory cardiogenic shock requiring short-term mechanical circulatory support:a proof of concept[J].Circulation,2019,140(1):98-100.
[5]	Shao J,Wen W,Yu Z,et al.Acute myocardial infarction complicated with cardiac arrest successfully managed by extracorporeal membrane oxygenation combined with intra-aortic balloon counterpulsation:a case report.[J].Zhonghua wei zhong bing ji jiu yi xue,2019,31(10):1289-1291.
[6]	罗明华,关怀敏,解金红,等.体外膜肺氧合联合主动脉球囊反搏支持下经皮冠状动脉介入救治高危冠心病10例总结[J].临床心血管病杂志,2019,35(7):620-624.
[7]	曹毅,李田昌,陈宇,等.体外膜肺氧合辅助下75岁以上高危冠心病患者经皮冠状动脉介入治疗观察[J].中华老年心脑血管病杂志,2021,23(1):34-37.
[8]	许志锋,韩振,吴永前,等.体外膜氧合联合主动脉球囊反搏及持续肾替代治疗在心脏术后心源性休克的应用[J].中国体外循环杂志,2020,18(1):25-29.
[9]	Dhruva SS,Ross JS,Mortazavi BJ,et al.Use of mechanical circulatory support devices among patients with acute myocardial infarction complicated by cardiogenic shock[J].JAMA Netw Open,2021,4(2):e2037748.
[10]	Fux T,Holm M,Corbascio M,et al.VA-ECMO support in nonsurgical patients with refractory cardiogenic shock:pre-implant outcome predictors[J].Artif Organs,2019,43(2):132-141.
[11]	Fux T,Holm M,Corbascio M,et al.Pre-implant outcome predictors in patients with refractory cardiogenic shock supported with VA-ECMO[J].J Am Coll Cardiol,2017,70(16):2094-2096.
[12]	Russo JJ,Aleksova N,Pitcher I,et al.Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock[J].J Am Coll Cardiol,2019,73(6):654-662.
[13]	Schrage B,Schneider S,Zeymer U,et al.Response by schrage et al to letter regarding article,"impella support for acute myocardial infarction complicated by cardiogenic shock:a matched-pair IABP-SHOCK II trial 30-day mortality analysis"[J].Circulation,2019,140(11):e559-e560.
[14]	Schmidt M,Burrell A,Roberts L,et al.Predicting survival after ECMO for refractory cardiogenic shock:the survival after veno-arterial-ECMO(SAVE)-score[J].Eur Heart J,2015,36(33):2246-2256.
[15]	Lüsebrink E,Orban M,Kupka D,et al.Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock[J].Eur Heart J,2020,41(38):3753-3761.
[16]	Schrage B,Becher PM,Bernhardt A,et al.Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation:results from an international,multicenter cohort study[J].Circulation,2020,142(22):2095-2106.
[17]	Dhruva SS,Ross JS,Mortazaviet BJ,et al.Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock.[J].JAMA,2020,323(8):734-745.
[18]	Fux T,Holm M,Corbascio M,et al.Pre-implant outcome predictors in patients with refractory cardiogenic shock supported with VA-ECMO[J].J Am Coll Cardiol,2017,70(16):2094-2096.
[19]	Thiele H,Jobs A,Ouweneel DM,et al.Percutaneous short-term active mechanical support devices in car-diogenic shock:a systematic review and collaborative meta-analysis of randomized trials[J].Eur Heart J,2017,38(47):3523-3531.
[20]	Pöss J,Köster J,Fuernau G,et al.Risk stratification for patients in cardiogenic shock after acute myocardial infarction[J].J Am Coll Cardiol,2017,69(15):1913-1920.
[21]	黄碧汉,巫焕珍,陈冬冬.主动脉内球囊反搏联合体外膜肺氧合治疗急性心肌梗死合并心源性休克1例[J].临床心血管病杂志,2018,34(12):1240-1243.